As of January 22, 2025, Liquidia Technologies (LQDA) has a market cap of $1.18 billion USD. According to our data, Liquidia Technologies is ranked No.4959 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.18 B |
18.62%
|
Dec 31, 2024 | $1.00 B |
-2.24%
|
Dec 29, 2023 | $1.02 B |
88.85%
|
Dec 30, 2022 | $0.54 B |
30.80%
|
Dec 31, 2021 | $0.41 B |
65.08%
|
Dec 31, 2020 | $0.25 B |
-31.07%
|
Dec 31, 2019 | $0.36 B |
-80.24%
|
Dec 31, 2018 | $1.83 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
United Therapeutics
UTHR
|
$16.58 B |
-0.000 M
|
USA
|
MannKind Corp
MNKD
|
$1.70 B |
0.000 M
|
USA
|
Insmed
INSM
|
$14.03 B |
0.000 M
|
USA
|
Amarin Corporation
AMRN
|
$0.22 B |
0.000 M
|
Ireland
|
Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
Amicus Therapeutics
FOLD
|
$2.85 B |
0.000 M
|
USA
|
Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
Corcept Therapeutics
CORT
|
$6.18 B |
0.000 M
|
USA
|
Market Cap | = | LQDA Stock Price | * | LQDA Shares Outstanding |
= | $13.95 | * | 84.64 M | |
= | $1.18 B |